Rafael G. Amado's Insider Trades & SAST Disclosures
Rafael G. Amado's most recent trade in Zai Lab Limited - ADR was a trade of 5,391 American Depositary Shares done . Disclosure was reported to the exchange on April 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Rafael G. Amado.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 5,391 | 48,207 (0%) | 0% | - | American Depositary Shares | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 5,391 | 10,782 | - | - | Restricted Share Units | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Sale of securities on an exchange or to another person at price $ 33.11 per share. | 03 Apr 2025 | 3,029 | 45,178 (0%) | 0% | 33.1 | 100,284 | American Depositary Shares |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 19,523 | 50,357 (0%) | 0% | - | American Depositary Shares | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 19,523 | 58,569 | - | - | Restricted Share Units | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Sale of securities on an exchange or to another person at price $ 35.89 per share. | 01 Apr 2025 | 7,541 | 42,816 (0%) | 0% | 35.9 | 270,677 | American Depositary Shares |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Sale of securities on an exchange or to another person at price $ 38.41 per share. | 17 Mar 2025 | 3,000 | 30,834 (0%) | 0% | 38.4 | 115,230 | American Depositary Shares |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 65,523 | 65,523 | - | - | Stock Options (Right to Buy) | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 21,294 | 21,294 | - | - | Restricted Share Units | |
| Poseida Therapeutics Inc | Rafael G. Amado | Director | 08 Jan 2025 | 58,950 | 0 | - | - | Common Stock | ||
| Poseida Therapeutics Inc | Rafael G. Amado | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Jan 2025 | 55,200 | 0 | - | - | Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Rafael G. Amado | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Jan 2025 | 27,350 | 0 | - | - | Stock Option (Right to Buy) | |
| Zai Lab Limited - ADR | G. Rafael Amado | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2024 | 21,000 | 41,417 (0%) | 0% | - | American Depositary Shares | |
| Zai Lab Limited - ADR | Rafael Amado G. | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2024 | 21,000 | 63,000 | - | - | Restricted Share Units | |
| Zai Lab Limited - ADR | Amado G. Rafael | See Remarks | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 30 Dec 2024 | 7,583 | 33,834 (0%) | 0% | 26.3 | 199,289 | American Depositary Shares |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Sale of securities on an exchange or to another person at price $ 16.20 per share. | 12 Aug 2024 | 3,115 | 20,417 (0%) | 0% | 16.2 | 50,463 | American Depositary Shares |
| Poseida Therapeutics Inc | Rafael G. Amado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 27,350 | 27,350 | - | - | Stock Option (Right to buy) | |
| Poseida Therapeutics Inc | Rafael G. Amado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 19,650 | 58,950 | - | 0 | Common Stock | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 5,391 | 16,173 | - | - | Restricted Share Units | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.90 per share. | 03 Apr 2024 | 5,391 | 25,484 (0%) | 0% | 15.9 | 85,717 | American Depositary Shares |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Sale of securities on an exchange or to another person at price $ 15.67 per share. | 03 Apr 2024 | 1,952 | 23,532 (0%) | 0% | 15.7 | 30,594 | American Depositary Shares |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 120,141 | 120,141 | - | - | Stock Options (Right to Buy) | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 78,092 | 78,092 | - | - | Restricted Share Units | |
| Zai Lab Limited - ADR | Rafael G. Amado | See Remarks | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 15 Mar 2024 | 2,544 | 20,093 (0%) | 0% | 18.9 | 47,980 | American Depositary Shares |
| Poseida Therapeutics Inc | Rafael G. Amado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 55,200 | 55,200 | - | - | Stock Option (Right to Buy) | |
| Poseida Therapeutics Inc | Rafael G. Amado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 39,300 | 39,300 | - | 0 | Common Stock | |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2022 | 19,120 | 550,410 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.83 per share. | 07 Oct 2022 | 8,464 | 541,946 (0%) | 0% | 11.8 | 100,099 | Common Stock |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.06 per share. | 03 Oct 2022 | 8,968 | 531,290 (0%) | 0% | 11.1 | 99,201 | Common Stock |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D and CMO | Sale of securities on an exchange or to another person at price $ 11.97 per share. | 02 Aug 2022 | 2,000 | 540,257 (0%) | 0% | 12.0 | 23,940 | Common Stock |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D and CMO | Sale of securities on an exchange or to another person at price $ 11.44 per share. | 05 Jul 2022 | 2,000 | 542,257 (0%) | 0% | 11.4 | 22,880 | Common Stock |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D and CMO | Sale of securities on an exchange or to another person at price $ 11.18 per share. | 21 Jun 2022 | 2,000 | 544,257 (0%) | 0% | 11.2 | 22,360 | Common Stock |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D and CMO | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 19 May 2022 | 11,500 | 546,257 (0%) | 0% | 7.4 | 85,092 | Common Stock |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 368,589 | 368,589 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D and CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 237,358 | 557,477 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Rafael G. Amado | EVP of R&D and CMO | Sale of securities on an exchange or to another person at price $ 7.71 per share. | 15 Mar 2022 | 5,169 | 320,119 (0%) | 0% | 7.7 | 39,848 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges